Close Menu
Newsward
  • World
  • US
    • Politics
  • Tech
    • Science/Tech
  • Money
    • Business and Market Watch
    • Crypto
    • Career
  • Health
    • Fitness
  • State of Women
  • Opinion
  • Sports
    • NFL
    • MLB

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Anthropic IPO Could Be Bitcoin's Next Catalyst: Arthur Hayes Turns 'Mini-Bulled Up' Ahead Of Nasdaq Listing – TradingView

November 12, 2026

Microsoft confirms Windows security updates installation issues

November 12, 2026

Democrat Scott Colom wins Mississippi 2026 Senate race, flipping seat in upset

November 12, 2026
Newsward
  • World
  • US
    • Politics
  • Tech
    • Science/Tech
  • Money
    • Business and Market Watch
    • Crypto
    • Career
  • Health
    • Fitness
  • State of Women
  • Opinion
  • Sports
    • NFL
    • MLB
Subscribe
Newsward
Home » Trying Tourette’s device tested by Lewis Capaldi was the best day of my life
Technology

Trying Tourette’s device tested by Lewis Capaldi was the best day of my life

By November 12, 2026No Comments1 Min Read
Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
Trying Tourette's device tested by Lewis Capaldi was the best
Share
Facebook Twitter LinkedIn Pinterest Email

Neupulse Devices for Tourette’s Syndrome Management

Overview of Neupulse Devices

The Tourettes Action charity has highlighted the existence of two distinct versions of a device known as Neupulse. These devices are aimed at assisting individuals affected by Tourette’s syndrome and managing associated tics.

Neupulse-C: A Consumer Wellness Device

The first variant, Neupulse-C, is categorized as a consumer wellness device. It is available to the general public and aims to provide individuals with a means of managing tics through non-medical channels.

Neupulse-M: A Medical Device in Development

In contrast, the Neupulse-M is designed specifically as a medical device targeted at the treatment of tics and Tourette’s syndrome. However, it is important to note that this version has not yet received regulatory approval for medical use.

Future Prospects

The introduction of the Neupulse-M device holds potential for advancing therapeutic options for individuals with Tourette’s syndrome. Its wait for regulatory approval marks a significant step for innovative treatments in the mental health space.

For more information on Tourette’s syndrome and available treatments, please refer to Tourettes Action.

Capaldi Day Device Lewis Life Tested Tourettes
Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
Previous ArticleSS United States completes final voyage, sinks to Gulf floor to become artificial reef
Next Article Opinion: Being a hater is a lost art – The Battalion

Related Posts

Microsoft confirms Windows security updates installation issues

November 12, 2026

3 longevity myths doctors say to stop believing

November 12, 2026

GTA 6 preorders top $1 billion as Hollywood eyes launch weekend

November 12, 2026

10 Tech Gifts Under $50 That Punch Above Their Price Point

November 12, 2026

Top Articles

AI translation sounds convincing, but it can be riddled with hidden errors

November 2, 2026

Drones Hit St. Petersburg Oil Terminals, VK Data Center, and Bridge

October 18, 2026

The Fight for the Future of Democratic Foreign Policy

November 3, 2026

Bitcoin, Ethereum, XRP Whipsaw On Nvidia Scandal, Iran Tensions: Crypto Sell-Off Sparks $1B Liquidation Wave

November 9, 2026

Don't Miss

Crypto

Anthropic IPO Could Be Bitcoin's Next Catalyst: Arthur Hayes Turns 'Mini-Bulled Up' Ahead Of Nasdaq Listing – TradingView

By November 12, 20260

Anthropic’s IPO: A Potential Catalyst for Bitcoin? Market participant Arthur Hayes expresses a positive outlook…

Microsoft confirms Windows security updates installation issues

November 12, 2026

Democrat Scott Colom wins Mississippi 2026 Senate race, flipping seat in upset

November 12, 2026

Racing Bulls commits to Lawson and Lindblad as 2027 F1 line-up

November 12, 2026

Subscribe to Updates

Subscribe to our newsletter and stay updated with the latest news and exclusive offers.

About Us
About Us

NEWSWARD is an independent news and media company covering the economy, politics, international affairs, and a changing world. Through articles, podcasts, video, and candid conversations, we connect major events to their impact on your life, your livelihood, and your future.

Our purpose is simple: help you understand what matters, think critically, and make informed decisions.

See what’s happening now. Know what’s next.

Don't Miss

Anthropic IPO Could Be Bitcoin's Next Catalyst: Arthur Hayes Turns 'Mini-Bulled Up' Ahead Of Nasdaq Listing – TradingView

November 12, 2026

Microsoft confirms Windows security updates installation issues

November 12, 2026

Democrat Scott Colom wins Mississippi 2026 Senate race, flipping seat in upset

November 12, 2026
Most Viewed

AI translation sounds convincing, but it can be riddled with hidden errors

November 2, 2026

Drones Hit St. Petersburg Oil Terminals, VK Data Center, and Bridge

October 18, 2026

The Fight for the Future of Democratic Foreign Policy

November 3, 2026
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Disclaimer
© 2026 Newsward. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.